Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MODD NASDAQ:NMTC NASDAQ:PAVM NYSE:RBOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMODDModular Medical$0.72-2.4%$0.72$0.63▼$2.65$39.95M0.1776,482 shs26,318 shsNMTCNeuroOne Medical Technologies$0.76+3.4%$0.78$0.40▼$1.39$38.21M0.68295,054 shs110,257 shsPAVMPAVmed$0.49+3.7%$0.54$0.30▼$1.90$10.64M1.08336,500 shs169,284 shsRBOTVicarious Surgical$6.19-2.4%$8.43$5.00▼$19.00$36.24M1.4136,760 shs18,386 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMODDModular Medical0.00%+0.38%+0.51%-14.98%-59.85%NMTCNeuroOne Medical Technologies0.00%-2.60%-2.29%+24.38%-0.78%PAVMPAVmed0.00%+3.52%-15.74%-20.46%-44.61%RBOTVicarious Surgical0.00%-7.48%-29.23%-19.15%-10.75%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMODDModular Medical0.4085 of 5 stars0.03.00.00.01.91.70.0NMTCNeuroOne Medical Technologies2.78 of 5 stars3.55.00.00.03.80.00.0PAVMPAVmed4.5868 of 5 stars3.55.00.04.32.90.01.9RBOTVicarious Surgical1.1834 of 5 stars2.02.00.00.01.82.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMODDModular Medical 0.00N/AN/AN/ANMTCNeuroOne Medical Technologies 3.00Buy$1.4589.74% UpsidePAVMPAVmed 3.00Buy$19.003,816.72% UpsideRBOTVicarious Surgical 2.00Hold$7.0013.18% UpsideCurrent Analyst Ratings BreakdownLatest PAVM, RBOT, MODD, and NMTC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/13/2025RBOTVicarious SurgicalPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.50 ➝ $7.006/6/2025PAVMPAVmedAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$19.50 ➝ $19.00(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMODDModular MedicalN/AN/AN/AN/A$0.21 per shareN/ANMTCNeuroOne Medical Technologies$3.45M11.08N/AN/A$0.16 per share4.78PAVMPAVmed$2.99M3.56N/AN/A$0.16 per share3.03RBOTVicarious SurgicalN/AN/AN/AN/A$3.89 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMODDModular Medical-$18.82M-$0.51N/A∞N/AN/A-185.60%-158.95%11/12/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.15N/A∞N/A-55.44%-163.49%-78.67%N/APAVMPAVmed$39.79M$1.160.42N/AN/A7,144.80%N/A-20.96%11/12/2025 (Estimated)RBOTVicarious Surgical-$63.22M-$10.09N/AN/AN/AN/A-148.14%-98.07%11/11/2025 (Estimated)Latest PAVM, RBOT, MODD, and NMTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q1 2026MODDModular Medical-$0.10-$0.12-$0.02-$0.12$0.20 millionN/A8/14/2025Q3 2025NMTCNeuroOne Medical Technologies-$0.05-$0.03+$0.02-$0.03$1.82 million$1.70 million8/12/2025Q2 2025RBOTVicarious Surgical-$2.61-$2.23+$0.38-$2.23N/AN/A6/20/2025Q4 2025MODDModular Medical-$0.11-$0.12-$0.01-$0.12N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMODDModular MedicalN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/APAVMPAVmedN/AN/AN/AN/AN/ARBOTVicarious SurgicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMODDModular MedicalN/A4.044.04NMTCNeuroOne Medical TechnologiesN/A7.135.80PAVMPAVmedN/A0.520.52RBOTVicarious SurgicalN/A5.115.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMODDModular Medical27.47%NMTCNeuroOne Medical Technologies16.07%PAVMPAVmed19.93%RBOTVicarious Surgical47.27%Insider OwnershipCompanyInsider OwnershipMODDModular Medical20.46%NMTCNeuroOne Medical Technologies8.90%PAVMPAVmed7.30%RBOTVicarious Surgical11.99%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMODDModular Medical2055.28 million43.97 millionNot OptionableNMTCNeuroOne Medical Technologies2050.00 million45.55 millionOptionablePAVMPAVmed9021.93 million20.33 millionOptionableRBOTVicarious Surgical2105.93 million5.22 millionNo DataPAVM, RBOT, MODD, and NMTC HeadlinesRecent News About These CompaniesVicarious Surgical to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceAugust 28 at 8:33 PM | tmcnet.comVicarious Surgical (NYSE:RBOT) Director Sells $18,445.10 in StockAugust 28 at 8:57 AM | insidertrades.comVicarious Surgical Faces Setback as Human Trials for Surgical Robot Are DelayedAugust 25, 2025 | aktiencheck.deADonald Tang Sells 2,059 Shares of Vicarious Surgical (NYSE:RBOT) StockAugust 22, 2025 | insidertrades.comRobotic surgery heats up with clearances and clinical trialsAugust 20, 2025 | crainsnewyork.comCVicarious Surgical (NYSE:RBOT) Given New $7.00 Price Target at Piper SandlerAugust 15, 2025 | marketbeat.comVicarious Surgical (NYSE:RBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.38 EPSAugust 14, 2025 | marketbeat.comVicarious Surgical’s Earnings Call: Progress Amid ChallengesAugust 14, 2025 | msn.comVicarious Surgical delays robot clinical timelineAugust 14, 2025 | finance.yahoo.comVicarious Surgical’s new CEO pushes back robot development timelineAugust 14, 2025 | fiercebiotech.comFVicarious Surgical delays robot timelineAugust 14, 2025 | finance.yahoo.comVicarious Surgical pushes back surgical robot timeline againAugust 13, 2025 | massdevice.comVicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | msn.comVicarious Surgical Reports Improved Q2 Financials and Leadership ChangeAugust 13, 2025 | msn.comVicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comVicarious Surgical anticipates FY25 cash burn of about $50MAugust 12, 2025 | msn.comVicarious Surgical reports Q2 EPS ($2.23), consensus ($2.50)August 12, 2025 | msn.comVicarious Surgical Reports Second Quarter 2025 Financial ResultsAugust 12, 2025 | businesswire.comVicarious Surgical (NYSE:RBOT) Stock Price Down 4.4% - What's Next?August 8, 2025 | marketbeat.comVicarious Surgical (RBOT) to Release Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comVicarious Surgical names Stephen From as next CEOAugust 2, 2025 | medtechdive.comMNew MarketBeat Followers Over TimeMedia Sentiment Over TimePAVM, RBOT, MODD, and NMTC Company DescriptionsModular Medical NASDAQ:MODD$0.72 -0.02 (-2.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.75 +0.03 (+4.33%) As of 08/29/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.NeuroOne Medical Technologies NASDAQ:NMTC$0.76 +0.03 (+3.42%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.75 -0.01 (-1.60%) As of 08/29/2025 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.PAVmed NASDAQ:PAVM$0.49 +0.02 (+3.65%) Closing price 08/29/2025 03:57 PM EasternExtended Trading$0.50 +0.01 (+2.66%) As of 08/29/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.Vicarious Surgical NYSE:RBOT$6.18 -0.16 (-2.44%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$6.16 -0.03 (-0.49%) As of 08/29/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
